Zobrazeno 1 - 10
of 2 134
pro vyhledávání: '"Seroneutralization"'
Autor:
Chege, Hannah1,2 (AUTHOR) h.chege@cgiar.org, Githigia, Samuel2 (AUTHOR) jkgathumbi@uonbi.ac.ke, Gathumbi, James2 (AUTHOR), Chege, Naomi1 (AUTHOR) naomichege22@gmail.com, Ojuok, Rose1 (AUTHOR) r.ojuok@cgiar.org, Odaba, Josiah1 (AUTHOR) j.odaba@cgiar.org, Mwalimu, Stephen1 (AUTHOR) smwalimu@ufl.edu, Oboge, Harriet1,2 (AUTHOR) harriet.oboge@wsu.edu, Steinaa, Lucilla1 (AUTHOR) l.steinaa@cgiar.org, Nene, Vishvanath1 (AUTHOR) v.nene@cgiar.org, Lacasta, Anna1 (AUTHOR) a.lacasta@cgiar.org
Publikováno v:
Antibodies (2073-4468). Dec2024, Vol. 13 Issue 4, p100. 10p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gozlan, Joël1,2 (AUTHOR) joel.gozlan@aphp.fr, Baron, Audrey3 (AUTHOR) audrey.baron@aphp.fr, Boyd, Anders4 (AUTHOR) anders.boyd@iplesp.upmc.fr, Salmona, Maud3,5 (AUTHOR) maud.salmona@aphp.fr, Fofana, Djeneba1 (AUTHOR) djeneba.fofana@aphp.fr, Minier, Marine3 (AUTHOR) marine.minier@aphp.fr, Gabassi, Audrey3 (AUTHOR) audrey.gabassi@aphp.fr, Morand-Joubert, Laurence1,6 (AUTHOR) laurence.morand-joubert@aphp.fr, Delaugerre, Constance3,7 (AUTHOR) constance.delaugerre@aphp.fr, Maylin, Sarah3 (AUTHOR) sarah.maylin@aphp.fr
Publikováno v:
Life (2075-1729). Jul2024, Vol. 14 Issue 7, p791. 13p.
Publikováno v:
The Journal of Infection
The Journal of infection, Vol. 83, no. 4, p. e4-e5 (2021)
The Journal of infection, Vol. 83, no. 4, p. e4-e5 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ecacea3775d86830c850a861e5a8723
http://europepmc.org/articles/PMC8364678
http://europepmc.org/articles/PMC8364678
Autor:
François Chable de la Héronnière, Jonathan Barthelemy, Guy R Takoudjou Dzomo, Fatima Abdelrazakh, Oumaima Djarma, Lucas Auguste, Abderrazzack A Fouda, Chatté Adawaye, Laurent Andreoletti, Mahamat Fayiz Abakar, Yannick Simonin, Sara Salinas, Franck JD Mennechet
Publikováno v:
Virus Research, Vol 350, Iss , Pp 199492- (2024)
Zika virus (ZIKV) is a major public health problem worldwide. After several reported outbreaks, the current extent of infections caused by this orthoflavivirus in the Sahel remains to be explored. We investigated the prevalence of neutralizing antibo
Externí odkaz:
https://doaj.org/article/02329edb2edb4ef48bbe27bd9328430e
Autor:
Douxfils J; Qualiblood s.a., Namur, Belgium; University of Namur, Department of Pharmacy, Namur Research Institute for Life Sciences, Rue de Bruxelles, 61, Namur 5000, Belgium. Electronic address: jonathan.douxfils@unamur.be., Gillot C; University of Namur, Department of Pharmacy, Namur Research Institute for Life Sciences, Rue de Bruxelles, 61, Namur 5000, Belgium., Mullier F; CHU UCL Namur, Université catholique de Louvain, Department of Laboratory Hematology, Namur Research Institute for Life Sciences, Yvoir, Belgium., Favresse J; University of Namur, Department of Pharmacy, Namur Research Institute for Life Sciences, Rue de Bruxelles, 61, Namur 5000, Belgium; Clinique Saint-Luc Bouge, Department of Laboratory Medicine, Namur, Belgium.
Publikováno v:
The Journal of infection [J Infect] 2021 Oct; Vol. 83 (4), pp. e4-e5. Date of Electronic Publication: 2021 Aug 15.
Autor:
Timothée Bruel, Jérôme Hadjadj, Piet Maes, Delphine Planas, Aymeric Seve, Isabelle Staropoli, Florence Guivel-Benhassine, Françoise Porrot, William-Henry Bolland, Yann Nguyen, Marion Casadevall, Caroline Charre, Hélène Péré, David Veyer, Matthieu Prot, Artem Baidaliuk, Lize Cuypers, Cyril Planchais, Hugo Mouquet, Guy Baele, Luc Mouthon, Laurent Hocqueloux, Etienne Simon-Loriere, Emmanuel André, Benjamin Terrier, Thierry Prazuck, Olivier Schwartz
The SARS-CoV-2 Omicron BA.1 variant has been supplanted in many countries by the BA.2 sub-lineage. BA.2 differs from BA.1 by about 21 mutations in its spike. Human anti-spike monoclonal antibodies (mAbs) are used for prevention or treatment of COVID-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd830c54b80b794dfde60399391145fa
https://doi.org/10.1101/2022.03.09.22272066
https://doi.org/10.1101/2022.03.09.22272066
Autor:
Guillemin F, Legrand K, Hélène Jeulin, Gégout-Petit A, Pierre Vallois, Agathe Bochnakian, Evelyne Schvoerer
BackgroundThe World Health Organisation recommends monitoring the circulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We aimed to estimate anti–SARS-CoV-2 total immunoglobulin (IgT) antibody seroprevalence and describe symp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59cf54caa2038155f0670c72e0a5f4bf
https://hal.archives-ouvertes.fr/hal-03269203
https://hal.archives-ouvertes.fr/hal-03269203
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.